BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32815912)

  • 1. The association between plasminogen activator inhibitor type-1 and clinical outcome in paediatric sepsis.
    Pudjiadi AH; Adhyanisitha K; Pusponegoro HD; Suyoko DEM; Satari HI; Kaswandani N
    Blood Coagul Fibrinolysis; 2020 Sep; 31(6):377-381. PubMed ID: 32815912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
    Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
    Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
    Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of inflammatory and hemostatic markers in sepsis and suspected disseminated intravascular coagulation.
    Hoppensteadt D; Tsuruta K; Hirman J; Kaul I; Osawa Y; Fareed J
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):120-7. PubMed ID: 24254894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
    Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
    Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.
    Sakata Y; Murakami T; Noro A; Mori K; Matsuda M
    Blood; 1991 May; 77(9):1949-57. PubMed ID: 1708294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis.
    Ikeda M; Matsumoto H; Ogura H; Hirose T; Shimizu K; Yamamoto K; Maruyama I; Shimazu T
    J Crit Care; 2018 Feb; 43():48-53. PubMed ID: 28843664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.
    Gando S; Nakanishi Y; Tedo I
    Crit Care Med; 1995 Nov; 23(11):1835-42. PubMed ID: 7587259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis in disseminated intravascular coagulation.
    Hack CE
    Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
    Gando S; Kameue T; Nanzaki S; Nakanishi Y
    Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation.
    Lertthammakiat S; Anantasit N; Anurathapan U; Sirachainan N; Kadegasem P; Chuansumrit A
    Thromb Haemost; 2017 Jul; 117(8):1471-1477. PubMed ID: 28492702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].
    Nagaizumi K; Kuroso K; Amano K; Sato T; Fukutake K; Fujimaki M
    Rinsho Byori; 1994 Jul; 42(7):707-12. PubMed ID: 8065036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.
    Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K
    Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Investigation of Coagulation Markers for Early Detection of Sepsis-Induced Disseminated Intravascular Coagulation: A Single-Center, Prospective Observational Study.
    Masuda T; Shoko T; Deguchi Y
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1082-1087. PubMed ID: 29552913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia.
    Binder A; Endler G; Müller M; Mannhalter C; Zenz W;
    J Thromb Haemost; 2007 Oct; 5(10):2049-54. PubMed ID: 17697137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
    Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
    Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E; Elsayh KI; Eltayeb AA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.